InvestorsHub Logo
Followers 1012
Posts 44391
Boards Moderated 0
Alias Born 03/17/2014

Re: None

Wednesday, 08/09/2023 8:01:27 AM

Wednesday, August 09, 2023 8:01:27 AM

Post# of 5006
Maxim Group Upgrades Vistagen Therapeutics to Buy, Announces $30 Price Target
7:09 pm ET August 7, 2023 (Benzinga) Print
Maxim Group analyst Jason McCarthy upgrades Vistagen Therapeutics (NASDAQ:VTGN) from Hold to Buy and announces $30 price target.

Latest Ratings for VTGN DateFirmActionFromTo

May 2021BairdInitiates Coverage OnOutperform Feb 2021JefferiesInitiates Coverage OnBuy Jan 2021William BlairUpgradesMarket PerformOutperform

View More Analyst Ratings for VTGN

View the Latest Analyst Ratings
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News